Table 1 Clinical characteristics of infected patients among different groups
Clinical characteristics | Group A No./Total (%) | Group B No./Total (%) | Group C No./Total (%) | Group D No./Total (%) |
|---|---|---|---|---|
Male | 56/93(60.22%) | 31/53(58.49%) | 42/91(46.15%) | 67/93(72.04%) |
Age (years) | Â | Â | Â | Â |
0–18 | 4/93(4.30%) | 4/53(7.55%) | 5/91(5.49%) | 9/93(9.68%) |
19–36 | 8/93(8.60%) | 5/53(9.43%) | 3/91(3.30%) | 3/93(3.23%) |
37–54 | 36/93(38.71%) | 20/53(37.74%) | 36/91(39.56%) | 30/93(32.26%) |
55–72 | 38/93(40.86%) | 19/53(35.85%) | 35/91(38.46%) | 38/93(40.86%) |
73–90 | 6/93(6.45%) | 4/53(7.55%) | 12/91(13.19%) | 13/93(13.98%) |
≥ 90 | 1/93(1.08%) | 1/53(1.89%) | 0 | 0 |
Department | Â | Â | Â | Â |
Intensive care unit (ICU) | 12/93(12.90%) | 7/53(13.21%) | 12/91(13.19%) | 42/93(45.16%) |
Urology | 14/93(15.05%) | 8/53(15.09%) | 25/91(27.47%) | 4/93(4.30%) |
Respiratory Medicine | 7/93(7.53%) | 1/53(1.89%) | 5/91(5.49%) | 5/93(5.38%) |
Pediatric | 2/93(2.15%) | 3/53(5.66%) | 1/91(1.10%) | 3/93(3.23%) |
Other | 58/93(62.37%) | 34/53(64.15%) | 48/91(52.75%) | 39/93(41.94%) |
Source of isolates | Â | Â | Â | Â |
Respiratory tract | 48/93(51.61%) | 16/53(30.19%) | 18/91(19.78%) | 47/93(50.54%) |
Urinary tract | 22/93(23.66%) | 13/53(24.53%) | 39/91(42.86%) | 10/93(10.75%) |
Blood | 3/93(3.23%) | 2/53(3.77%) | 5/91(5.49%) | 3/93(3.23%) |
Other | 20/93(21.51%) | 22/53(41.51%) | 29/91(31.87%) | 33/93(35.48%) |